Advertisement
Screener

CALYPTE BIOMEDICAL CORP Concentration Risk, Percentage

CALYPTE BIOMEDICAL CORP Concentration Risk, Percentage

CALYPTE BIOMEDICAL CORP reported Concentration Risk, Percentage of 90.00% for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-12-31.

Discontinued › Notes

us-gaap:ConcentrationRiskPercentage1 · last filed 2012-12-31

  • 2012-09-30: Concentration Risk, Percentage 9 month 90.00%.
  • 2011-09-30: Concentration Risk, Percentage 9 month 82.00%.
Period endConcentration Risk, Percentage 9 month
2012-09-3090.00%
10-Q · filed 2012-12-31
2011-09-3082.00%
10-Q · filed 2012-12-31